PHPSX
Price
$16.90
Change
+$0.47 (+2.86%)
Updated
Apr 17 closing price
Net Assets
2.16M
RYVLX
Price
$394.61
Change
-$0.29 (-0.07%)
Updated
Apr 17 closing price
Net Assets
579.64M
Ad is loading...

PHPSX vs RYVLX

Header iconPHPSX vs RYVLX Comparison
Open Charts PHPSX vs RYVLXBanner chart's image
ProFunds Pharmaceuticals UltraSector Svc
Price$16.90
Change+$0.47 (+2.86%)
VolumeN/A
Net Assets2.16M
Rydex NASDAQ-100® 2x Strategy A
Price$394.61
Change-$0.29 (-0.07%)
VolumeN/A
Net Assets579.64M
PHPSX vs RYVLX Comparison Chart
Loading...
View a ticker or compare two or three
VS
PHPSX vs. RYVLX commentary
Apr 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PHPSX is a Hold and RYVLX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
RYVLX has more cash in the bank: 580M vs. PHPSX (2.16M). PHPSX (0.00) and RYVLX (0.00) have matching dividends . PHPSX was incepted earlier than RYVLX: PHPSX (25 years) vs RYVLX (21 years). PHPSX (3.50) is less costly to investors than RYVLX (2.01). RYVLX is a more actively managed with annual turnover of: 392.00 vs. PHPSX (207.00). RYVLX has a lower initial minimum investment than PHPSX: RYVLX (2500) vs PHPSX (15000). RYVLX annual gain was more profitable for investors over the last year : -8.31 vs. PHPSX (-12.09). RYVLX return over 5 years is better than : 120.77 vs. PHPSX (-11.04).
PHPSXRYVLXPHPSX / RYVLX
Total Expense Ratio2.781.90146%
Annual Report Gross Expense Ratio3.502.01174%
Fund Existence25 years21 years-
Gain YTD-19.815-28.27470%
Front LoadN/A5%-
Min. Initial Investment150002500600%
Min. Initial Investment IRAN/AN/A-
Net Assets2.16M580M0%
Annual Yield % from dividends0.000.00-
Returns for 1 year-12.09-8.31146%
Returns for 3 years-34.0416.75-203%
Returns for 5 years-11.04120.77-9%
Returns for 10 years-28.25415.25-7%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FCSRX8.19N/A
N/A
Fidelity Advisor Strategic Real Ret C
RRGTX6.90N/A
N/A
DWS RREEF Global Real Estate Secc S
PHLCX11.33N/A
N/A
PGIM Jennison Health Sciences C
PRJZX39.33N/A
N/A
PGIM Jennison Global Opportunities Z
JHFEX11.68N/A
N/A
JHancock Fundamental Equity Inc I